prostate cancer: radiation approaches for advanced disease andrew l. salner, md facr director helen...

11
PROSTATE CANCER: PROSTATE CANCER: RADIATION APPROACHES RADIATION APPROACHES for advanced disease for advanced disease ANDREW L. SALNER, MD FACR ANDREW L. SALNER, MD FACR DIRECTOR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT HARTFORD HOSPITAL, CT

Upload: erick-doyle

Post on 16-Jan-2016

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: PROSTATE CANCER: RADIATION APPROACHES for advanced disease ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT

PROSTATE CANCER:PROSTATE CANCER:RADIATION APPROACHESRADIATION APPROACHES

for advanced diseasefor advanced disease

ANDREW L. SALNER, MD FACRANDREW L. SALNER, MD FACRDIRECTORDIRECTOR

HELEN & HARRY GRAY CANCER CENTERHELEN & HARRY GRAY CANCER CENTERHARTFORD HOSPITAL, CTHARTFORD HOSPITAL, CT

Page 2: PROSTATE CANCER: RADIATION APPROACHES for advanced disease ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT

ARS

???

Page 3: PROSTATE CANCER: RADIATION APPROACHES for advanced disease ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT

Advanced DiseaseAdvanced Disease

Biochemical recurrence after Biochemical recurrence after prostatectomyprostatectomy

Metastatic diseaseMetastatic disease Palliative external RTPalliative external RT QuadrametQuadramet

Page 4: PROSTATE CANCER: RADIATION APPROACHES for advanced disease ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT

Salvage Radiation Therapy for Salvage Radiation Therapy for Biochemical RecurrenceBiochemical Recurrence

Recurrence>2years, PSA DT>10 monthsRecurrence>2years, PSA DT>10 months Positive margin, extracapsular extensionPositive margin, extracapsular extension Should be used early, PSA<1(possibly Should be used early, PSA<1(possibly

0.5)0.5) 50-70% DFS in 5 years50-70% DFS in 5 years IMRT 60-70 Gy, image guidance dailyIMRT 60-70 Gy, image guidance daily acceptable early complications, rare late acceptable early complications, rare late

complicationscomplications

Page 5: PROSTATE CANCER: RADIATION APPROACHES for advanced disease ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT

Choo, R-Mayo Clinic 2009 IJROBP

Page 6: PROSTATE CANCER: RADIATION APPROACHES for advanced disease ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT

Bone MetastasisBone Metastasis

Pain/loss of functionPain/loss of function Spinal cord compression>emergencySpinal cord compression>emergency Hip metastasis causes pain, threatens Hip metastasis causes pain, threatens

fracturefracture One dominant siteOne dominant site Multiple sitesMultiple sites

Page 7: PROSTATE CANCER: RADIATION APPROACHES for advanced disease ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT

Spine radiation to osteoblastic lesion

Page 8: PROSTATE CANCER: RADIATION APPROACHES for advanced disease ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT

Palliative RadiationPalliative RadiationBone MetastasisBone Metastasis

Highly effective 90% or more for pain reliefHighly effective 90% or more for pain relief Can be repeatedCan be repeated Short course of 2 weeks, occasionally Short course of 2 weeks, occasionally

even given in single dose, depending on even given in single dose, depending on locationlocation

Can be combined with chemo, hormone Can be combined with chemo, hormone deprivation, bone stabilization such as deprivation, bone stabilization such as vertebroplasty or fusion if neededvertebroplasty or fusion if needed

Page 9: PROSTATE CANCER: RADIATION APPROACHES for advanced disease ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT

Quadramet(samarium 153)Quadramet(samarium 153) Bone seeking radioisotopeBone seeking radioisotope Systemic dose to “hot” areasSystemic dose to “hot” areas Can combine with externalCan combine with external May lower blood countsMay lower blood counts May cause “flare”May cause “flare” Can last 3-6 monthsCan last 3-6 months Can be repeatedCan be repeated 60-75% response rate60-75% response rate Best for patients with multipleBest for patients with multiple

or migratory painful sitesor migratory painful sites

Page 10: PROSTATE CANCER: RADIATION APPROACHES for advanced disease ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT

Advanced prostate cancerAdvanced prostate cancer

Team approach with urologist, medical Team approach with urologist, medical and radiation oncologistand radiation oncologist

Systemic therapies and local therapiesSystemic therapies and local therapies Focus on disease control and quality of lifeFocus on disease control and quality of life Individually tailoredIndividually tailored THANK YOU!THANK YOU!

Page 11: PROSTATE CANCER: RADIATION APPROACHES for advanced disease ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT

Advanced Stage DiseaseSession Evaluation

???